Alzheimer's dementia (AD) is increasingly being recognized as one of the most important medical and social problems in older people in industrialized and non-industrialized nations. To date, only symptomatic treatments exist for this disease, all trying to counterbalance the neurotransmitter disturbance. Three cholinesterase inhibitors (CIs) are currently available and have been approved for the treatment…
Therapeutic Advances in Neurological Disorders Template
Write in a clean editor, then format for Therapeutic Advances in Neurological Disorders in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Therapeutic Advances in Neurological Disorders format
Therapeutic Advances in Neurological Disorders is a peer-reviewed journal published by SAGE, covering Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Acute Ischemic Stroke Management.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Neurological Disorders, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Neurological Disorders style. No sign-up. |
| Publishes research in | Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Acute Ischemic Stroke Management Polyomavirus and related diseases Neurological disorders and treatments |
| ISSN | 1756-2856 |
| Citation impact (2-yr) | 3.94 |
| h-index | 91 |
| i10-index | 651 |
| Total citations | 34,052 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | Ruhr University Bochum |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Therapeutic Advances in Neurological Disorders per year
Citation impact of Therapeutic Advances in Neurological Disorders by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Therapeutic Advances in Neurological Disorders
Multiple sclerosis (MS) is universally found to be more prevalent in women than men. This has led to extensive studies of differences in the immune system or nervous system between women and men, which might be caused by the effects of gonadal hormones, genetic differences, and different environmental exposures and modern lifestyle in men and…
Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is a significant limiting factor in medication maintenance. Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects on cognitive function and therefore compromise patient wellbeing. On the other hand, some agents may serve to enhance cognitive…
BACKGROUND AND AIMS: The National Multiple Sclerosis Society and other expert organizations recommended that all patients with multiple sclerosis (MS) should be vaccinated against COVID-19. However, the effect of disease-modifying therapies (DMTs) on the efficacy to mount an appropriate immune response is unknown. We aimed to characterize humoral immunity in mRNA-COVID-19 MS vaccinees treated with…
Dementia involves progressive and often remorseless decline in cognition, function, behaviour and care needs. Assessment in dementia relies on collateral as well as patient-derived information. Many assessment scales have been developed over decades for use in dementia research and care. These scales are used to reduce uncertainty in decision making, for example in screening for…